Back in June, lung cancer patient advocate extraordinaire, CraiginPA (his online handle), let me know about a lung cancer education conference for patients in Boston on September 6th. The focus of the conference..."acquired resistance," a subject near and dear to my heart lungs. ("Acquired [drug] resistance" occurs when a chemotherapy no longer works to control cancer growth, after it has worked for a while.) With my oral chemo, Xalkori, there seems to be some variability in how well it works, how long it works and which side effects users experience. However, the common fact for all patients on Xalkori is that it won't work forever. Some patients see benefits from it for only a few months while others have been successfully treated with it for a few years. Why Xalkori works longer for some patients and not for others is unknown. We know, from clinical trials, that when Xalkori is stopped, the cancer tends to come back ...
Comments
Post a Comment